Faculty
Education:
2013 Humboldt University of Berlin Ph.D. (Cell Biology)
2007 College of Pharmaceutical Sciences, Zhejiang University M.Sc. Med. (Pharmacology)
2005 Zhejiang University B.Sc. Med. (Pharmaceutical Sciences) & B.Sc. (Biotechnology)
Work Experience:
2017-present Southern University of Science and Technology Research Associate Professor
2013-2017 Max Delbrück Center for Molecular Medicine Postdoc
2007-2008 Charité University Medicine Research Assistant
Research Areas:
Establish organoid culture platform from patient material, and develop economic, stable new materials for organoid culture.
Model the development of tumor formation with organoid culture, study the interplay between tumor-associated mutations, and identify biomarkers for tumor diagnostic.
Publications:
Zhu Q*, Fang L*, Heuberger J, Kranz A, Schipper J, Scheckenbach K, Vidal RO, Sunage-Franze DY, Müller M, Wulf-Goldenberg A, Sauer S, Birchmeier W. The Wnt-driven Mll1 Epigenome Regulates Salivary Gland and Head and Neck Cancer. Cell Reports 2018 accepted. (Co-first author)
Fang L, Zhu Q, Neuenschwander M, Specker E, Wulf-Goldenberg A, Birchmeier W. A small-molecule antagonist of the beta-catenin/TCF4 interaction blocks the self-renewal of cancer stem cells and suppresses tumorigenesis. Cancer Research 2016 Feb 15;76(4):891-901.
Holland JD, Gyorffy B, Vogel R, Eckert K, Valenti G, Fang L, Lohneis P, Elezkurtaj S, Ziebold U, Birchmeier W. Combined Wnt/beta-Catenin, Met, and CXCL12/CXCR4 Signals Characterize Basal Breast Cancer and Predict Disease Outcome. Cell Reports 2013;5(5):1214-27.
Wend P, Fang L, Zhu Q, Schipper JH, Loddenkemper C, Kosel F, Brinkmann V, Eckert K, Hindersin S, Holland JD, Lehr S, Kahn M, Ziebold U, Birchmeier W. Wnt/beta-catenin signalling induces MLL to create epigenetic changes in salivary gland tumours. Embo J. 2013 Jul 17;32(14):1977-89.